Concise Review: The High Cost of High Tech Medicine: Planning Ahead for Market Access

Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation

(2016) Gregory A. Abel et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Asymmetric Thinking about Return on Investment

(2016) David A. Asch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Goals for Pay for Performance in Hematopoietic Cell Transplantation: A Primer

(2015) C. Frederick LeMaistre et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Optimal Benefits for Hematopoietic Stem Cell Transplantation: A Consensus Opinion

(2014) Richard T. Maziarz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impact of the Affordable Care Act on Stem Cell Transplantation

(2014) Stephanie Farnia et al.   Current Hematologic Malignancy Reports

Projections of the Cost of Cancer Care in the United States: 2010-2020

(2011) A. B. Mariotto et al.   JNCI-Journal of the National Cancer Institute

Cancer's Next Frontier

(2010) Elena B. Elkin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE